Global Coronary Artery Bypass Graft Market Size, Share, Growth Analysis Report - Forecast 2034

Coronary Artery Bypass Graft Market: Industry Perspective

The global coronary artery bypass graft market size was worth around USD 12.74 Billion in 2024 and is predicted to grow to around USD 34.80 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 9.7% between 2025 and 2034. The report analyzes the global coronary artery bypass graft market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the coronary artery bypass graft industry.

Request Free Sample           

Coronary Artery Bypass Graft Market: Overview

Coronary artery bypass graft (CABG) is a surgical procedure used to treat coronary artery disease (CAD), a condition where the blood vessels that supply oxygen-rich blood to the heart become blocked or narrowed. The coronary artery bypass graft (CABG) market has a significant impact on the healthcare industry and the economy as a whole. Technological advancements are playing an important role in the CABG industry. Innovations in minimally invasive procedures, robotic-assisted surgeries, and imaging technologies have supported the market development. Such developments have improved patient recovery time and increased the success rate of CABG procedures. On the flip side, CABG procedures are complex and often require specialized equipment, skilled healthcare professionals, and post-operative care.

Key Insights

• As per the analysis shared by our research analyst, the global coronary artery bypass graft market is estimated to grow annually at a CAGR of around 9.7% over the forecast period (2025-2034).
• Regarding revenue, the global coronary artery bypass graft market size was valued at around USD 12.74 Billion in 2024 and is projected to reach USD 34.80 Billion by 2034.
• The coronary artery bypass graft market is projected to grow at a significant rate due to Rising prevalence of coronary artery disease and aging population fuel demand. Advancements in surgical techniques and graft materials support market growth.
• Based on Type, the On-pump CABG segment is expected to lead the global market.
• On the basis of Procedure, the Single CABG segment is growing at a high rate and will continue to dominate the global market.
• Based on the End-user, the Hospitals segment is projected to swipe the largest market share.
• By Technique, the Conventional segment is expected to dominate the global market.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Coronary Artery Bypass Graft Market: Growth Drivers

Increasing prevalence of cardiovascular diseases

One of the major drivers of the CABG market is the rising prevalence of cardiovascular diseases, specifically coronary artery disease (CAD). CAD is a leading cause of death globally. It affects millions of people worldwide and is responsible for a significant burden on healthcare systems. As per the WHO, an estimated 18 million people die each year from CVDs, accounting for 31% of all global deaths. Regions such as North America and Europe have had higher rates of CAD due to factors such as an unhealthy diet, sedentary lifestyle, high prevalence of obesity, and smoking. In addition, incidence has been on the rise in many Asian countries, including China and India Owing to growing urbanization and the adoption of a westernized lifestyle. CAD is a leading cause of mortality and morbidity worldwide, and CABG is a widely used surgical procedure for treating severe cases. As the incidence of CAD continues to rise, the demand for CABG procedures is expected to increase, augmenting the global coronary artery bypass graft market growth.

Coronary Artery Bypass Graft Market: Restraints

Growing burden of surgical risks

CABG is an invasive surgical procedure that involves opening the chest and temporarily stopping the heart. As with any surgery, it carries inherent risks such as bleeding, infection, adverse reactions to anesthesia, and complications related to the use of cardiopulmonary bypass. These risks are more significant in patients with comorbidities or advanced age. Furthermore, CABG requires specialized cardiac surgical teams and advanced healthcare facilities with the necessary infrastructure and equipment which would, in turn, further hamper the overall coronary artery bypass graft market development to some extent.

Coronary Artery Bypass Graft Market: Opportunities

Advancement in new technologies coupled with rising investments by key players

Technological advancements in surgical techniques are offering ample opportunity to the players in the coronary artery bypass graft industry. One recent advancement in coronary artery bypass graft (CABG) procedures is the utilization of minimally invasive techniques. Due to advancements, it is noted that there has been significant improvement in the safety and efficacy of CABG procedures. Minimally invasive techniques, robot-assisted surgeries, advanced graft materials, and imaging modalities aid in better patient outcomes, reduced hospital stays, and faster recovery times. These advancements create opportunities for healthcare providers to offer state-of-the-art CABG procedures and attract patients seeking advanced treatment options.

Coronary Artery Bypass Graft Market: Segmentation

The global Coronary Artery Bypass Graft market is segmented based on type, procedure, end-user,technique, and region

Based on type, the global coronary artery bypass graft market is divided into On-pump, off-pump, minimally invasive direct. the off-pump segment accounted for the majority share of the overall market in 2022 and accounted for a share of over 50% of the total revenue. Associated benefits such as shorter hospital stays, smaller incisions, and faster recovery have supported the segment growth to a great extent.

On the basis of procedure, the global coronary artery bypass graft market is bifurcated into single cabg, double cabg, triple cabg, quadruple cabg. Of which, the single CABG surgery category recorded the lion’s revenue share of more than 30%, expanding at a CAGR of over 9% during the study period. It is noted that CABG treatment is highly dependent on one or more cardiac arteries that are blocked. On the flip side, the Triple CABG Surgery segment is projected to grow at the fastest growth rate during the study period.

In terms of end-user, the market is segregated into the global coronary artery bypass graft market is split into hospitals, cardiac centers, ambulatory surgical centers. Of these, the hospital segment accounted for the highest revenue share during the year 2022.

In terms of technique, the global coronary artery bypass graft market is categorized into conventional, endoscopic, robot-assisted.

Coronary Artery Bypass Graft Market: Report Scope

Coronary Artery Bypass Graft Market: Regional Analysis

North America is expected to dominate the market during the forecast period

The global Coronary Artery Bypass Graft market share is dominated by North America. The North American market is projected to experience a steady CAGR over the years. The North American CABG market is competitive, with various medical device companies and healthcare providers offering CABG procedures and related products. Prominent companies in the market include Medtronic, Edwards Lifesciences, Abbott Laboratories, Terumo Corporation, and LivaNova, among others.

On the other side, advancements in surgical techniques and imaging technologies have improved the safety & efficacy of CABG procedures which would, in turn, act as an important driving factor for the Asia Pacific market growth.

Recent Developments:

• Recently in August 2022, Medtronic announced the completion of its acquisition of Affera, Inc. Affera company is a medical technology company dedicated to delivering unrivaled innovative solutions to address the rapidly growing cardiac arrhythmia market. This collaboration is aimed at increasing the cardiovascular product portfolio of the company.
• Grand Pharmaceutical Group of China announced its investment of EUR 15 million in Xeltis in August 2022. Headquarters in the Netherlands, this company is a renowned medical device firm. Grand Pharmaceutical has created a polymer-based restorative device for cardiovascular treatment.

Coronary Artery Bypass Graft Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the coronary artery bypass graft market on a global and regional basis.

The global coronary artery bypass graft market is dominated by players like:

• Medtronic
• Edwards Lifesciences
• Terumo Corporation
• Guidant Group
• Vitalitec International Inc.
• MAQUET Holding B.V.
• Novadaq Technologies Inc.
• KARL STORZ GmbH & Co. KG
• Genesee Biomedical Inc.
• Sorin Group

The global coronary artery bypass graft market is segmented as follows;

By Type

• On-pump
• Off-pump
• Minimally Invasive Direct

By Procedure

• Single CABG
• Double CABG
• Triple CABG
• Quadruple CABG

By End-user

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers

By Technique

• Conventional
• Endoscopic
• Robot-assisted

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa